Hori A - Search Results

1

Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor.

Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M. Ohtaki T, et al. Among authors: hori a. Nature. 2001 May 31;411(6837):613-7. doi: 10.1038/35079135. Nature. 2001. PMID: 11385580

2

Metastin suppresses the motility and growth of CHO cells transfected with its receptor.

Hori A, Honda S, Asada M, Ohtaki T, Oda K, Watanabe T, Shintani Y, Yamada T, Suenaga M, Kitada C, Onda H, Kurokawa T, Nishimura O, Fujino M. Hori A, et al. Biochem Biophys Res Commun. 2001 Sep 7;286(5):958-63. doi: 10.1006/bbrc.2001.5470. Biochem Biophys Res Commun. 2001. PMID: 11527393

3

Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers.

Oshima T, Sato S, Kato J, Ito Y, Watanabe T, Tsuji I, Hori A, Kurokawa T, Kokubo T. Oshima T, et al. Among authors: hori a. Mol Cancer. 2013 Jun 12;12:60. doi: 10.1186/1476-4598-12-60. Mol Cancer. 2013. PMID: 23758976 Free PMC article.

4

Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey.

Oshima T, Miyashita H, Ishimura Y, Ito Y, Tanaka Y, Hori A, Kokubo T, Kurokawa T. Oshima T, et al. Among authors: hori a. PLoS One. 2018 May 3;13(5):e0196422. doi: 10.1371/journal.pone.0196422. eCollection 2018. PLoS One. 2018. PMID: 29723247 Free PMC article.

5

Chemistry and anti-tumor activity of sperabillin polymers.

Hida T, Tsubotani S, Hori A, Murakami M, Natsugari H, Kozai Y, Harada S. Hida T, et al. Among authors: hori a. Chem Pharm Bull (Tokyo). 1993 May;41(5):889-93. doi: 10.1248/cpb.41.889. Chem Pharm Bull (Tokyo). 1993. PMID: 8339336

6

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.

Tamamura H, Hori A, Kanzaki N, Hiramatsu K, Mizumoto M, Nakashima H, Yamamoto N, Otaka A, Fujii N. Tamamura H, et al. Among authors: hori a. FEBS Lett. 2003 Aug 28;550(1-3):79-83. doi: 10.1016/s0014-5793(03)00824-x. FEBS Lett. 2003. PMID: 12935890 Free article.

7

Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo.

Hori A, Imaeda Y, Kubo K, Kusaka M. Hori A, et al. Cancer Lett. 2002 Sep 8;183(1):53-60. doi: 10.1016/s0304-3835(02)00110-6. Cancer Lett. 2002. PMID: 12049814

8

A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.

Awazu Y, Nakamura K, Mizutani A, Kakoi Y, Iwata H, Yamasaki S, Miyamoto N, Imamura S, Miki H, Hori A. Awazu Y, et al. Among authors: hori a. Mol Cancer Ther. 2013 Jun;12(6):913-24. doi: 10.1158/1535-7163.MCT-12-1011. Epub 2013 Apr 2. Mol Cancer Ther. 2013. PMID: 23548264

9

Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells.

Hori A, Ikeyama S, Sudo K. Hori A, et al. Biochem Biophys Res Commun. 1994 Nov 15;204(3):1067-73. doi: 10.1006/bbrc.1994.2571. Biochem Biophys Res Commun. 1994. PMID: 7980579

10

MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody.

Farrell PJ, Matuszkiewicz J, Balakrishna D, Pandya S, Hixon MS, Kamran R, Chu S, Lawson JD, Okada K, Hori A, Mizutani A, Iwata H, de Jong R, Hibner B, Vincent P. Farrell PJ, et al. Among authors: hori a. Mol Cancer Ther. 2017 Jul;16(7):1269-1278. doi: 10.1158/1535-7163.MCT-16-0771. Epub 2017 Mar 24. Mol Cancer Ther. 2017. PMID: 28341789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters